News for Silo Pharma Inc. (SILO)

SARASOTA, FL, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. ( SILO) (”œSilo” or the ”œCompany”), a developmental stage biopharmaceutical company

**media[551416]**

SPC-15 combination treatment shows enhanced efficacy in combating stress-induced psychiatric disorders SARASOTA, FL, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Silo

**media[537549]**

Shares of Zoomcar Holdings Inc ZCAR rose sharply in today's pre-market trading after the company announced a significant achievement in its financial performanc...

U.S. stocks traded slightly lower midway through trading, with the Dow Jones index falling around 0.1% on Wednesday. The Dow traded down 0.05% to 42,507.21 whi...

U.S. stocks traded lower this morning, with the Dow Jones index falling around 0.2%% on Wednesday. Following the market opening Wednesday, the Dow traded down ...

**media[509427]**

**media[504215]**

Silo Pharma stock is rising after announcing a collaboration with Kymanox to develop a subcutaneous insertion device for its SP-26 chronic pain treatment.

Prototype development and feasibility testing underway for optimized subcutaneous delivery SARASOTA, FL, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc.

Silo Pharma stock hits 52-week low at $0.83 amid market challenges

Dual-action approach combining 5-HT4R Agonist (SPC-15) and NMDAR antagonist demonstrates enhanced efficacy in preclinical study for managing severe conditions

Loading... Loading... Shares of Selective Insurance Group, Inc. SIGI fell sharply during Friday's session following weak quarterly results. Selective Insuranc...

Loading... Loading... Shares of The Charles Schwab Corporation SCHW fell sharply during Tuesday's session following second-quarter results. Charles Schwab sai...

Connecticut-based Rallybio Corporation (RLYB), a clinical-stage biotechnology company is up over 90 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

Connecticut-based Rallybio Corporation (RLYB), a clinical-stage biotechnology company is up over 90 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

The growing frequency of chronic diseases such as asthma, arthritis, chronic obstructive pulmonary disease (COPD), and others is driving up demand for...

Vancouver, Kelowna, Delta, BC - May 26, 2023 (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces its w...